Taylor Wealth Management Partners Alnylam Pharmaceuticals, Inc. Transaction History
Taylor Wealth Management Partners
- $176 Million
- Q2 2022
A detailed history of Taylor Wealth Management Partners transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Taylor Wealth Management Partners holds 24,190 shares of ALNY stock, worth $6.06 Million. This represents 2.0% of its overall portfolio holdings.
Number of Shares
24,190
Previous 26,056
7.16%
Holding current value
$6.06 Million
Previous $4.26 Million
17.09%
% of portfolio
2.0%
Previous 1.72%
Shares
13 transactions
Others Institutions Holding ALNY
# of Institutions
667Shares Held
112MCall Options Held
839KPut Options Held
771K-
Capital World Investors Los Angeles, CA16.6MShares$4.16 Billion0.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.7MShares$3.19 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.39 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA6.97MShares$1.75 Billion0.35% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.38MShares$1.1 Billion0.64% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $30.8B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...